Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Centr Brands Corp C.CNTR

Alternate Symbol(s):  CNTRF

Centr Brands Corp. is a Canada-based wellness beverage company. The Company is engaged in development and marketing of beverages infused with hemp-derived extracts and derivatives. The Company is focused on the sales and development of a non-alcoholic beverages for cannabidiol (CBD) infused beverage industry. It offers a range of functional wellness beverages that support individuals in their pursuit of balanced and healthy lifestyles. The Company’s products include CENTR, CENTR Instant, CENTR CBD, CENTR Sugar Free, and CENTR Enhanced. The Company’s CENTR and CENTR Sugar Free is a low-calorie CBD beverage. Its CENTR Enhanced is a zero calorie, nootropic and adaptogen-enriched non-CBD functional beverage. Its CENTR Instant is an adaptogen-based CBD powder.


CSE:CNTR - Post by User

Post by EndZonefor7on Jun 03, 2020 12:10pm
323 Views
Post# 31106962

The White House reviewing FDA CBD plan

The White House reviewing FDA CBD plan Positive to finally hear of some movement. 


The White House is currently reviewing a federal plan for marijuana and CBD research.

“We recognize that there is substantial public interest in marketing and accessing CBD for a variety of products. We are working toward a goal of providing additional guidance, and have made substantial progress,” FDA said in a statement. "


https://www.marijuanamoment.net/the-white-house-is-reviewing-cbd-and-marijuana-research-guidance-from-fda/








<< Previous
Bullboard Posts
Next >>